Increasingly, the design of clinical trials is shifting from traditional methods to more pragmatic and adaptive styles to incentivise participation in clinical trials A paper …
-
-
[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies
-
[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches
-
What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)
-
Accelerating Commercialization of Rare Disease Treatments
-
[Whitepaper] Unique Patient Challenges & Support Solutions in Rare Disease
